Amneal Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMNEAL PHARM, and what generic and branded alternatives to AMNEAL PHARM drugs are available?
AMNEAL PHARM has two hundred and twenty-three approved drugs.
There are six tentative approvals on AMNEAL PHARM drugs.
Summary for Amneal Pharm
US Patents: | 0 |
Tradenames: | 176 |
Ingredients: | 171 |
NDAs: | 223 |
Patent Litigation for Amneal Pharm: | See patent lawsuits for Amneal Pharm |
PTAB Cases with Amneal Pharm as petitioner: | See PTAB cases with Amneal Pharm as petitioner |
Drugs and US Patents for Amneal Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal Pharms | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 207342-002 | Jul 11, 2018 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Amneal Pharms | IRBESARTAN | irbesartan | TABLET;ORAL | 204740-001 | Apr 17, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amneal Pharm | FLECAINIDE ACETATE | flecainide acetate | TABLET;ORAL | 075442-003 | Jul 31, 2001 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amneal Pharms | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 204178-001 | Dec 11, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amneal Pharms Ny | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 040757-001 | Aug 25, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Amneal Pharms Ny | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 040746-001 | Aug 25, 2006 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for AMNEAL PHARM drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
Similar Applicant Names
Here is a list of applicants with similar names.